Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This study is intended to show whether inhaled chemotherapy can be added to a standard IV chemotherapy regime, to investigate the additional toxicities and to show initial evidence of efficacy of the combination.
Epistemonikos ID: 24fe8085f09116ee3d771d94400a035aa47cfce7
First added on: May 04, 2024